Results 181 to 190 of about 53,403 (325)

EBV-positive small cell neuroendocrine carcinoma of the nasopharynx with cervical lymph node metastasis: a case report and literature review. [PDF]

Front Oncol
Xue J, Ma W, Liu X, Wang Y, Wang X, Li Z, Tian Y, Liu Q, Dong F.   +8 more
europepmc   +1 more source

Crosstalk Between Intratumoral Microbes and Tumor Immunity: Implications for Tumor Therapy

Cancer Medicine, Volume 15, Issue 2, February 2026.
ABSTRACT Background Emerging studies indicate that microbes are present in tumor cells and immune cells. Intratumoral microbiota (ITM) constitute an important component of the tumor immune microenvironment (TIME) and have an important impact on tumor progression and treatment. Objective Through the general elaboration of ITM represented by bacteria and
Fengxue Li, Lili Qiao, Xinquan Liang, Yingying Zhang, Ning Liang, Jian Xie, Guodong Deng, Yuying Hao, Pingping Hu, Xue Wu, Fangjie Ding, Can Feng, Yiming Mu, Jiandong Zhang   +13 more
wiley   +1 more source

Evaluation of Anti-BNLF2b Antibody and Epstein-Barr Virus Biomarkers for the Diagnosis of Nasopharyngeal Carcinoma: A Retrospective Study. [PDF]

Technol Cancer Res Treat
Deng H, Liu Q, Shen H, Xiao P.
europepmc   +1 more source

Two case reports on central nervous system metastasis from nasopharyngeal carcinoma and a literature review. [PDF]

Discov Oncol
Zheng G, Liu Y, Lin S, Weng Q, Liu X, Wu W.   +5 more
europepmc   +1 more source

Human papilloma virus (HPV) infection as an etiological factor in malignant sinonasal neoplasms and nasopharyngeal carcinomas: A pathologist’s perspective

, 2019
Farhana Zakaria, Carol Fernandes
openalex   +1 more source

Single‐cell sequencing for cancer precision medicine: From mechanism discovery to diagnosis and therapeutics

Clinical and Translational Discovery, Volume 6, Issue 1, February 2026.
Single‐cell sequencing overcomes bulk sequencing limitations, enabling high‐resolution multi‐omics analysis at the single‐cell level. It reveals tumour heterogeneity, identifying key subpopulations and tumour microenvironment interactions driving progression and resistance.
Yue Zhao, Hancong Li, Huanzuo Yang, Gongshuang Zhang, Xinyue Fu, Peiheng Li, Puxing He, Shuang Wu, Han Luo   +8 more
wiley   +1 more source

Targeting oncogenic acetyltransferase NAT10 to overcome anti-PD-1 resistance in nasopharyngeal carcinoma. [PDF]

J Immunother Cancer
Zhao Y.
europepmc   +1 more source

GPR183‐mediated activation of PI3K is a potential biomarker for immunotherapy in lung cancer

Clinical and Translational Discovery, Volume 6, Issue 1, February 2026.
Anti‐PD1 treatment and PI3Kγ inhibition had remarkable therapeutic performance on CD4+ Tcm and CD4+ Tn in lung cancer through potential regulation of PI3K pathway with participation of GPR183. Abstract Background As one of commonly used immune checkpoint inhibition therapies, PD1 monoclonal antibodies exhibit a promising cancer immunotherapy approach ...
Ling Ye, Nannan Zheng, Fangming Liu, Huirong Fu, Yifei Liu, Ying Yang, Ruixue Qi, Duojiao Wu, Lin Shi, Dongli Song   +9 more
wiley   +1 more source

Discontinuation of immunotherapy and its effect on prognosis in recurrent or metastatic nasopharyngeal carcinoma patients: a retrospective analysis. [PDF]

Cancer Immunol Immunother
Peng Y, Chu X, Zha D, Meng L, Yao J, Liu T, Liu Q, Xu X, Wang S, Chen M, You R, Liu Y.   +11 more
europepmc   +1 more source

deltaHED predicts survival and immune evasion in PD‐1 blockade therapy: A multi‐cohort study across three cancer types

Clinical and Translational Medicine, Volume 16, Issue 2, February 2026.
deltaHED predicts survival and immune evasion in PD‐1 blockade therapy: a multi‐cohort study across three cancer types. deltaHED quantifies germlinesomatic HLA‐I divergence and predicts survival and immune evasion in PD‐1 blockade therapy. Across nasopharyngeal carcinoma, melanoma, and esophageal squamous cell carcinoma, high deltaHED is associated ...
Jianying Xu, Xiaoli Wei, Jicheng Yao, Ujjwal Mukund Mahajan, Ulf Dietrich Kahlert, Run Shi, Kaiying Zhang, Ahmed Alnatsha, Zhengyi Qian, Fei Han, Fenghua Wang   +10 more
wiley   +1 more source